Kevin P. Cross

1.9k total citations
41 papers, 735 citations indexed

About

Kevin P. Cross is a scholar working on Computational Theory and Mathematics, Cancer Research and Molecular Biology. According to data from OpenAlex, Kevin P. Cross has authored 41 papers receiving a total of 735 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Computational Theory and Mathematics, 11 papers in Cancer Research and 9 papers in Molecular Biology. Recurrent topics in Kevin P. Cross's work include Computational Drug Discovery Methods (19 papers), Carcinogens and Genotoxicity Assessment (11 papers) and Analytical Chemistry and Chromatography (8 papers). Kevin P. Cross is often cited by papers focused on Computational Drug Discovery Methods (19 papers), Carcinogens and Genotoxicity Assessment (11 papers) and Analytical Chemistry and Chromatography (8 papers). Kevin P. Cross collaborates with scholars based in United States, United Kingdom and Italy. Kevin P. Cross's co-authors include Paul E. Blower, Glenn J. Myatt, David J. Ponting, Luis G. Valerio, Chihae Yang, William Fisanick, Andrew Rusinko, David M. DeMarini, Lidiya Stavitskaya and Patricia A. Escobar and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Medicinal Chemistry and Toxicology and Applied Pharmacology.

In The Last Decade

Kevin P. Cross

38 papers receiving 685 citations

Peers

Countries citing papers authored by Kevin P. Cross

Since Specialization

Citations

This map shows the geographic impact of Kevin P. Cross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin P. Cross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin P. Cross more than expected).

Fields of papers citing papers by Kevin P. Cross

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin P. Cross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin P. Cross. The network helps show where Kevin P. Cross may publish in the future.

Co-authorship network of co-authors of Kevin P. Cross

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin P. Cross. A scholar is included among the top collaborators of Kevin P. Cross based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin P. Cross. Kevin P. Cross is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Novel (Q)SAR models for prediction of reversible and time-dependent inhibition of cytochrome P450 enzymes 2025 ·Frontiers in Pharmacology ·(unknown), Arianna Bassan, Kevin P. Cross, Xinning Yang, Glenn J. Myatt, Donna A. Volpe, Lidiya Stavitskaya	1
2	An in silico protocol for endocrine activity assessment: Integrating predictions, experimental evidence, and expert reviews across estrogen, androgen, thyroid, and steroidogenesis modalities 2025 ·Computational Toxicology ·Candice Johnson, Sue Marty, Marlene T. Kim, Kevin M. Crofton, Alessandra Roncaglioni, Arianna Bassan, Tara S. Barton‐Maclaren, Ana Patrícia Domingues, Markus Frericks, Agnes L. Karmaus, Sunil Kulkarni, Elena Lo Piparo, Stephanie Melching‐Kollmuss, (unknown), David Woolley, Kevin P. Cross	0
3	Mechanisms of Nitrosamine Mutagenicity and Their Relationship to Rodent Carcinogenic Potency 2024 ·Chemical Research in Toxicology ·David J. Snodin, Alejandra Trejo‐Martin, David J. Ponting, G. Smith, Andreas Czich, Kevin P. Cross, Laura Custer, (unknown), Nigel Greene, Amit S. Kalgutkar, S. A. Stalford, Rachael E. Tennant, Esther Vock, Adam Zalewski, (unknown), Krista L. Dobo	28
4	Medical device report analyses from MAUDE: Device and patient outcomes, adverse events, and sex-based differential effects 2024 ·Regulatory Toxicology and Pharmacology ·(unknown), Lynn M. Crosby, Kevin P. Cross, Minjun Chen, Rosalie K. Elespuru	2
5	Analysis of chemical structures and mutations detected by Salmonella TA98 and TA100 2023 ·Mutation research. Fundamental and molecular mechanisms of mutagenesis ·Kevin P. Cross, David M. DeMarini	8
6	Implementation of In Silico Toxicology Protocols in Leadscope 2022 ·Methods in molecular biology ·Kevin P. Cross, Candice Johnson, Glenn J. Myatt	2
7	Use of less-than-lifetime (LTL) durational limits for nitrosamines: Case study of N-Nitrosodiethylamine (NDEA) 2021 ·Regulatory Toxicology and Pharmacology ·Joel P. Bercu, (unknown), George E. Johnson, Andreas Czich, Susanne Glowienke, Michelle Kenyon, Robert Thomas, David J. Ponting, Angela White, Kevin P. Cross, (unknown), (unknown)	20
8	Implementation of in silico toxicology protocols within a visual and interactive hazard assessment platform 2021 ·Computational Toxicology ·Glenn J. Myatt, Arianna Bassan, Dave Bower, Candice Johnson, Scott A. Miller, Manuela Pavan, Kevin P. Cross	3
9	Evaluating confidence in toxicity assessments based on experimental data and in silico predictions 2021 ·Computational Toxicology ·Candice Johnson, Lennart T. Anger, Romualdo Benigni, (unknown), Frank Bringezu, Kevin M. Crofton, M Cronin, Kevin P. Cross, (unknown), Markus Frericks, Fjodor Melnikov, Scott A. Miller, David W. Roberts, (unknown), Alessandra Roncaglioni, Elena Lo Piparo, Raymond R. Tice, Craig Zwickl, Glenn J. Myatt	10
10	Revisiting the bacterial mutagenicity assays: Report by a workgroup of the International Workshops on Genotoxicity Testing (IWGT) 2020 ·Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·Rita Schoeny, Kevin P. Cross, David M. DeMarini, Rosalie K. Elespuru, Atsushi Hakura, Dan D. Levy, Richard V. Williams, Errol Zeiger, Patricia A. Escobar, Jonathan Howe, Masayuki Kato, (unknown), Martha M. Moore, Stéphanie Simon, Leon F. Stankowski, Kei‐ichi Sugiyama, Bas‐jan M. van der Leede	6
11	Development of improved QSAR models for predicting the outcome of the in vivo micronucleus genetic toxicity assay 2020 ·Regulatory Toxicology and Pharmacology ·(unknown), Naomi L. Kruhlak, (unknown), Kevin P. Cross, Alexander Sedykh, Lidiya Stavitskaya	12
12	Management of pharmaceutical ICH M7 (Q)SAR predictions – The impact of model updates 2020 ·Regulatory Toxicology and Pharmacology ·Catrin Hasselgren, Joel P. Bercu, (unknown), Kevin P. Cross, Susanne Glowienke, Naomi L. Kruhlak, Wolfgang Muster, John Nicolette, M. Vijayaraj Reddy, Roustem Saiakhov, Krista L. Dobo	26
13	Are all bacterial strains required by OECD mutagenicity test guideline TG471 needed? 2019 ·Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·Richard V. Williams, David M. DeMarini, Leon F. Stankowski, Patricia A. Escobar, Errol Zeiger, Jonathan Howe, Rosalie K. Elespuru, Kevin P. Cross	47
14	Transitioning to composite bacterial mutagenicity models in ICH M7 (Q)SAR analyses 2019 ·Regulatory Toxicology and Pharmacology ·(unknown), Marlene T. Kim, Naomi L. Kruhlak, Kevin P. Cross, Roustem Saiakhov, Suman Chakravarti, Lidiya Stavitskaya	21
15	Delivering an Automated and Integrated Approach to Combination Screening Using Acoustic-Droplet Technology 2015 ·SLAS TECHNOLOGY ·Kevin P. Cross, (unknown), (unknown), (unknown), Sandeep Daya, Mark E. Roberts, Shaun R. Hawley, (unknown), Beverley Isherwood	5
16	The ToxBank Data Warehouse: Supporting the Replacement of In Vivo Repeated Dose Systemic Toxicity Testing 2013 ·Molecular Informatics ·Pekka Kohonen, Emilio Benfenati, (unknown), Rebecca Ceder, Michael Crump, Kevin P. Cross, Roland C. Grafström, Lyn Healy, Christoph Helma, Nina Jeliazkova, Vedrin Jeliazkov, Silvia Maggioni, Scott A. Miller, Glenn J. Myatt, Micha Rautenberg, Glyn Stacey, Egon Willighagen, (unknown), Barry Hardy	24
17	Characterization and validation of an in silico toxicology model to predict the mutagenic potential of drug impurities* 2012 ·Toxicology and Applied Pharmacology ·Luis G. Valerio, Kevin P. Cross	39
18	Computational analysis for hepatic safety signals of constituents present in botanical extracts widely used by women in the United States for treatment of menopausal symptoms 2010 ·Regulatory Toxicology and Pharmacology ·(unknown), Jinhui Dou, Kevin P. Cross, Luis G. Valerio	18
19	Comparison of Methods for Sequential Screening of Large Compound Sets 2006 ·Combinatorial Chemistry & High Throughput Screening ·Paul E. Blower, Kevin P. Cross, Gabriel S. Eichler, Glenn J. Myatt, John N. Weinstein, Chihae Yang	6
20	Decision Tree Methods in Pharmaceutical Research 2005 ·Current Topics in Medicinal Chemistry ·Paul E. Blower, Kevin P. Cross	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact